hydrogen carbonate has been researched along with Peritonitis in 37 studies
Bicarbonates: Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
hydrogencarbonate : The carbon oxoanion resulting from the removal of a proton from carbonic acid.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two experimental studies were carried out upon dogs to clarify the efficacy of peritoneal povidone-iodine lavage in peritonitis." | 7.66 | Peritoneal lavage with povidone-iodine solution in experimentally induced peritonitis. ( Lores, ME; Ortíz, JR; Rosselló, PJ, 1981) |
| "Two experimental studies were carried out upon dogs to clarify the efficacy of peritoneal povidone-iodine lavage in peritonitis." | 3.66 | Peritoneal lavage with povidone-iodine solution in experimentally induced peritonitis. ( Lores, ME; Ortíz, JR; Rosselló, PJ, 1981) |
| "Numerous studies have confirmed beneficial effects of polyglucose dialysis solution (PG-DS), an amino acid dialysis solution (AA-DS), and bicarbonate (bic) or bicarbonate/lactate (bic/lac) buffered solutions on selected components of peritoneal bioavailability or clinical parameters of peritoneal dialysis (PD) patients." | 2.45 | Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome? ( Grzegorzewska, AE, 2009) |
| "Any degree of microinflammation is an independent risk factor for mortality for patients with chronic kidney disease in all stages." | 1.43 | [Systemic and intraperitoneal inflammation in peritoneal dialysis patients]. ( Opatrná, S, 2016) |
| "Peritonitis was induced in Sprague-Dawley rats by cecal ligation and fecal spillage." | 1.29 | Gastric intramural PCO2 during peritonitis and shock. ( Bisera, J; Desai, VS; Tang, W; Weil, MH; Yang, G, 1993) |
| "Peritonitis is the main cause of drop out (22%), while loss of peritoneal membrane efficiency accounts for 7%, patient's choice 14%, catheter complications 14%, inability to cope 8%, clinical problems 20% and other reasons 15%." | 1.28 | CAPD in a large population: a 7-year experience. ( Belardi, P; Beltrame, G; Boero, R; Bonello, F; Guarena, C; Maffei, S; Piccoli, G; Quarello, F; Scalzo, B, 1989) |
| "Peritonitis is the most important complication of continuous ambulatory peritoneal dialysis (CAPD)." | 1.27 | Peritonitis in continuous ambulatory peritoneal dialysis patients. ( Barnes, T; Bower, JD; Hellems, E; Humphries, J; Ray, R; Rubin, J; Teal, N, 1983) |
| "The diffuse peritonitis is a syndrome during the course of which biochemical reactive chains are activated according to a cascade principle." | 1.27 | [New therapeutic aspects in the treatment of diffuse peritonitis]. ( Bruch, HP; Conrad, F; Döll, W; Imhof, M; Oppelt, M; Schmidt, E, 1987) |
| "We conclude that alkalosis is counteracted by a metabolic compensation due to the non volatile and lactic acid." | 1.26 | [The question of "lactate alkalosis": animal experiments and a case report]. ( Förster, H; Hartmann, H; Steuer, A, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (35.14) | 18.7374 |
| 1990's | 11 (29.73) | 18.2507 |
| 2000's | 11 (29.73) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opatrná, S | 1 |
| Montenegro, J | 2 |
| Grzegorzewska, AE | 1 |
| Pawlaczyk, K | 2 |
| Holmes, CJ | 4 |
| Czekalski, S | 1 |
| Breborowicz, A | 2 |
| Lindholm, B | 1 |
| Pletinck, A | 1 |
| Vanholder, R | 1 |
| Veys, N | 1 |
| Van Biesen, W | 1 |
| DAWSON, GR | 1 |
| WOOD, TJ | 1 |
| Haas, S | 1 |
| Schmitt, CP | 1 |
| Arbeiter, K | 1 |
| Bonzel, KE | 1 |
| Fischbach, M | 1 |
| John, U | 1 |
| Pieper, AK | 1 |
| Schaub, TP | 1 |
| Passlick-Deetjen, J | 3 |
| Mehls, O | 1 |
| Schaefer, F | 1 |
| Lameire, N | 1 |
| Mortier, S | 1 |
| Faict, D | 4 |
| Schalkwijk, CG | 1 |
| Lameire, NH | 1 |
| De Vriese, AS | 1 |
| Scheingraber, S | 1 |
| Boehme, J | 1 |
| Scharbert, G | 1 |
| Dralle, H | 1 |
| Ahmad, S | 1 |
| Sehmi, JS | 1 |
| Ahmad-Zakhi, KH | 1 |
| Clemenger, M | 1 |
| Levy, JB | 1 |
| Brown, EA | 1 |
| Saracho, R | 1 |
| Gallardo, I | 1 |
| Martínez, I | 1 |
| Muñoz, R | 1 |
| Quintanilla, N | 1 |
| Theodoridis, M | 1 |
| Passadakis, P | 1 |
| Kriki, P | 1 |
| Gioka, T | 1 |
| Panagoutsos, S | 1 |
| Mourvati, E | 1 |
| Thodis, E | 1 |
| Kantartzi, K | 1 |
| Vargemezis, V | 1 |
| Rubin, J | 1 |
| Ray, R | 1 |
| Barnes, T | 1 |
| Teal, N | 1 |
| Hellems, E | 1 |
| Humphries, J | 1 |
| Bower, JD | 1 |
| Oreopoulos, DG | 1 |
| Khanna, R | 2 |
| Williams, P | 1 |
| Vas, SI | 1 |
| Lores, ME | 1 |
| Ortíz, JR | 1 |
| Rosselló, PJ | 1 |
| Förster, H | 1 |
| Hartmann, H | 1 |
| Steuer, A | 1 |
| Stack, AM | 1 |
| Saladino, RA | 1 |
| Thompson, C | 1 |
| Sattler, F | 1 |
| Weiner, DL | 1 |
| Parsonnet, J | 1 |
| Nariuchi, H | 1 |
| Siber, GR | 1 |
| Fleisher, GR | 1 |
| Dobos, GJ | 2 |
| Böhler, J | 2 |
| Kuhlmann, J | 2 |
| Elsner, J | 1 |
| Andre, M | 1 |
| Schollmeyer, PJ | 1 |
| Sennesael, JJ | 1 |
| De Smedt, GC | 1 |
| Van der Niepen, P | 1 |
| Verbeelen, DL | 1 |
| Desai, VS | 1 |
| Weil, MH | 1 |
| Tang, W | 1 |
| Yang, G | 1 |
| Bisera, J | 1 |
| Suzuki, K | 1 |
| Nolph, KD | 1 |
| Moore, HL | 1 |
| Twardowski, ZJ | 1 |
| Burger, M | 1 |
| Schollmeyer, P | 1 |
| MacLeod, A | 1 |
| Grant, A | 1 |
| Donaldson, C | 1 |
| Khan, I | 1 |
| Campbell, M | 1 |
| Daly, C | 1 |
| Lawrence, P | 1 |
| Wallace, S | 1 |
| Vale, L | 1 |
| Cody, J | 1 |
| Fitzhugh, K | 1 |
| Montague, G | 1 |
| Ritchie, C | 1 |
| MacKenzie, RK | 2 |
| Moseley, A | 2 |
| Jenkins, JP | 1 |
| Williams, JD | 2 |
| Coles, GA | 2 |
| Topley, N | 2 |
| Kuzlan-Pawlaczyk, M | 1 |
| Wieczorowska-Tobis, K | 1 |
| Polubinska, A | 1 |
| Wisniewska, J | 1 |
| Jones, S | 1 |
| Argyle, R | 1 |
| Pu, K | 1 |
| Boles, C | 1 |
| Krumhaar, I | 1 |
| Müller, V | 1 |
| Reinschke, P | 1 |
| Schambye, HT | 1 |
| Flesner, P | 1 |
| Pedersen, RB | 1 |
| Hardt-Madsen, M | 1 |
| Chemnitz, J | 1 |
| Christensen, HK | 1 |
| Detmer, A | 1 |
| Pedersen, FB | 1 |
| Yamamoto, T | 1 |
| Sakakura, T | 1 |
| Yamakawa, M | 1 |
| Quarello, F | 1 |
| Bonello, F | 1 |
| Boero, R | 1 |
| Maffei, S | 1 |
| Beltrame, G | 1 |
| Belardi, P | 1 |
| Scalzo, B | 1 |
| Guarena, C | 1 |
| Piccoli, G | 2 |
| Imhof, M | 1 |
| Schmidt, E | 1 |
| Bruch, HP | 1 |
| Oppelt, M | 1 |
| Conrad, F | 1 |
| Döll, W | 1 |
| Onushko, KG | 1 |
| Bordiuzhevich, IV | 1 |
| Wilson, RF | 2 |
| Gibson, D | 1 |
| Percinel, AK | 1 |
| Ali, MA | 1 |
| Baker, G | 1 |
| LeBlanc, LP | 1 |
| Lucas, C | 1 |
| Sarver, EJ | 1 |
| LeBlanc, PL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of a Biocompatible Peritoneal Dialysis Solution (Delflex Neutral pH) on Mesothelial Cell Viability and Peritoneal Transport[NCT01292863] | 0 participants (Actual) | Interventional | 2011-03-31 | Withdrawn (stopped due to Study was modified to in vitro design and no longer involves participants) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for hydrogen carbonate and Peritonitis
| Article | Year |
|---|---|
Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?
Topics: Bicarbonates; Biological Availability; Dialysis Solutions; Disease-Free Survival; Glucans; Humans; I | 2009 |
Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
Topics: Bicarbonates; Biocompatible Materials; Dialysis Solutions; Female; Follow-Up Studies; Humans; Kidney | 2012 |
Volume control in peritoneal dialysis patients: role of new dialysis solutions.
Topics: Acidosis; Bicarbonates; Blood Volume; Double-Blind Method; Glucans; Glucose; Glycation End Products, | 2004 |
Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
Topics: Acetates; Bicarbonates; Buffers; Cellulose; Costs and Cost Analysis; Dialysis Solutions; Efficiency; | 1998 |
4 trials available for hydrogen carbonate and Peritonitis
| Article | Year |
|---|---|
Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
Topics: Acidosis; Adolescent; Bicarbonates; Buffers; Child; Child, Preschool; Cross-Over Studies; Dialysis S | 2003 |
Monitoring of acid-base and regulating variables during abdominal lavage.
Topics: Abdomen, Acute; Acid-Base Imbalance; Adult; Aged; Alkalosis; Analysis of Variance; Bicarbonates; Blo | 2004 |
Impact of new dialysis solutions on peritonitis rates.
Topics: Bicarbonates; Dialysis Solutions; Humans; Kidney Failure, Chronic; Lactic Acid; Peritoneal Dialysis; | 2006 |
In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
Topics: Adult; Aged; Bicarbonates; Dialysis Solutions; Female; Humans; Hydrogen-Ion Concentration; Lactic Ac | 2000 |
29 other studies available for hydrogen carbonate and Peritonitis
| Article | Year |
|---|---|
[Systemic and intraperitoneal inflammation in peritoneal dialysis patients].
Topics: Bicarbonates; Dialysis Solutions; Glucans; Glucose; Humans; Icodextrin; Inflammation; Peritoneal Dia | 2016 |
[Peritoneal dialysis solutions].
Topics: Adult; Bicarbonates; Buffers; Child; Follow-Up Studies; Glucose; Glycation End Products, Advanced; H | 2008 |
Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
Topics: Animals; Bicarbonates; Dialysis Solutions; Inflammation; Lactates; Male; Peritoneal Dialysis; Perito | 2009 |
A CASE OF POST-OPERATIVE APNOEA RESPONDING TO INTRAVENOUS SODIUM BICARBONATE INFUSION.
Topics: Acidosis; Apnea; Atropine; Bicarbonates; Bis-Trimethylammonium Compounds; Gallamine Triethiodide; Hu | 1964 |
EXPERIENCES WITH PERITONEAL DIALYSIS.
Topics: Bicarbonates; Dialysis; Drainage; Equipment and Supplies; Fluid Therapy; Hemoperitoneum; Humans; Kid | 1965 |
Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Topics: Amino Acids; Animals; Bicarbonates; Buffers; Dialysis Solutions; Female; Glucose; Glycation End Prod | 2004 |
Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
Topics: Bicarbonates; Buffers; Dialysis Solutions; Female; Humans; Incidence; Male; Middle Aged; Peritoneal | 2007 |
The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Topics: Aged; Bicarbonates; Biocompatible Materials; Biomarkers; CA-125 Antigen; Cell Survival; Cohort Studi | 2008 |
Peritonitis in continuous ambulatory peritoneal dialysis patients.
Topics: Bicarbonates; Blood Glucose; Blood Proteins; Diabetic Nephropathies; Family Characteristics; Glomeru | 1983 |
Continuous ambulatory peritoneal dialysis - 1981.
Topics: Bicarbonates; Blood Urea Nitrogen; Calcium; Catheterization; Erythropoiesis; Hospitalization; Humans | 1982 |
Peritoneal lavage with povidone-iodine solution in experimentally induced peritonitis.
Topics: Acidosis; Animals; Bicarbonates; Disease Models, Animal; Dogs; Female; Humans; Ileum; Ligation; Peri | 1981 |
[The question of "lactate alkalosis": animal experiments and a case report].
Topics: Alkalosis; Animals; Appendicitis; Bicarbonates; Female; Humans; Injections, Intravenous; Lactates; M | 1980 |
Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
Topics: Animals; Antibodies, Monoclonal; Bicarbonates; Blood Pressure; Disease Models, Animal; Drug Evaluati | 1995 |
Bicarbonate-based dialysis solution preserves granulocyte functions.
Topics: Actins; Bicarbonates; Chemotaxis, Leukocyte; Complement C5a; Dialysis Solutions; Humans; Neutrophils | 1994 |
The impact of peritonitis on peritoneal and systemic acid-base status of patients on continuous ambulatory peritoneal dialysis.
Topics: Acid-Base Equilibrium; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bicarbonates; Carbon Di | 1994 |
Gastric intramural PCO2 during peritonitis and shock.
Topics: Animals; Bicarbonates; Carbon Dioxide; Gastric Mucosa; Hemodynamics; Hydrogen-Ion Concentration; Isc | 1993 |
Effects of bicarbonate dialysis solution on peritoneal transport in rats.
Topics: Animals; Bicarbonates; Capillary Permeability; Cell Membrane Permeability; Dialysis Solutions; Male; | 1996 |
Improved cytosolic free calcium mobilization and superoxide production in bicarbonate-based peritoneal dialysis solution.
Topics: Bicarbonates; Calcium; Cytosol; Dialysis Solutions; Glucose; Humans; Hydrogen-Ion Concentration; In | 1997 |
Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
Topics: Aged; Bicarbonates; Buffers; Dialysis Solutions; Female; Glucose; Humans; In Vitro Techniques; Lacta | 1998 |
Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Topics: Animals; Bicarbonates; Cell Count; Creatinine; Cytokines; Dialysis Solutions; Glucose; Inflammation | 1999 |
Post-operative management of equine abdominal patients.
Topics: Abdomen; Animals; Bicarbonates; Blood Proteins; Drainage; Gastrointestinal Motility; Hematocrit; Hor | 1975 |
[The clinical picture of acute abdomen in chronic renal insufficiency].
Topics: Abdomen, Acute; Adult; Bicarbonates; Colitis; Creatinine; Diagnosis, Differential; Digestive System; | 1975 |
Bicarbonate- versus lactate-based CAPD fluids: a biocompatibility study in rabbits.
Topics: Animals; Bicarbonates; Biocompatible Materials; Catheters, Indwelling; Dialysis Solutions; Lactates; | 1992 |
[Neutralized continuous ambulatory peritoneal dialysis dialysate].
Topics: Acidosis; Bicarbonates; Dialysis Solutions; Humans; Hydrogen-Ion Concentration; Peritoneal Dialysis, | 1991 |
CAPD in a large population: a 7-year experience.
Topics: Acetates; Adult; Aged; Bicarbonates; Dialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chr | 1989 |
[New therapeutic aspects in the treatment of diffuse peritonitis].
Topics: Animals; Bicarbonates; Blood Pressure; Hydrogen-Ion Concentration; Peritoneal Lavage; Peritonitis; R | 1987 |
[Peritoneal dialysis with the aid of Dialaflex-61].
Topics: Adult; Bicarbonates; Calcium; Female; Humans; Magnesium; Male; Middle Aged; Peritoneal Dialysis; Per | 1973 |
Severe alkalosis in critically ill surgical patients.
Topics: Alkalosis; Alkalosis, Respiratory; Bicarbonates; Extracorporeal Circulation; Female; Humans; Male; P | 1972 |
Factors affecting hemodynamics in clinical shock with sepsis.
Topics: Abscess; Arteries; Bacterial Infections; Bicarbonates; Blood Pressure; Blood Volume; Cardiac Output; | 1971 |